Comparison of two dosing methods for immediate administration of tolvaptan in acute decompensated heart failure

Mitsutoshi Oguri, Hideki Ishii, Shiou Ohguchi, Kunihiko Takahara, Yoshihiro Kawamura, Yuki Yokoi, Kazuhiro Izumi, Hiroshi Takahashi, Haruo Kamiya, Toyoaki Murohara

研究成果: Article査読

4 被引用数 (Scopus)

抄録

Background: The clinical dosing method for tolvaptan in patients with acute heart failure (HF) is still unclear. We aimed to compare the differences in clinical effect between two dosing regimens: once-daily 7.5 mg and twice-daily 3.75 mg. Methods: In this randomized trial, tolvaptan was administered within 12 h from hospital admission. The primary outcome was the serial change in congestion scores measured every day from enrollment until dosing day 7. Outcomes including safety parameters were also evaluated. Results: The subjects were assigned to either the once-daily 7.5 mg dosing regimen (N = 15) or the twice-daily 3.75 mg dosing regimen (N = 16). The time-course changes in body weight, serum sodium and creatinine levels, systolic blood pressure, daily urine output, and congestion scores were similar between the two groups. In the twice-daily 3.75 mg dosing group, the serum sodium levels on days 3 and 4 were significantly (p < 0.05) increased compared with those on day 1. The congestion scores significantly (p < 0.05) decreased from day 2 to day 7 in both groups compared with those on day 1. However, the difference in the serial change in the congestion scores did not reach statistical significance. Conclusions: Our present results suggest that the early administration of tolvaptan within 12 h after hospital admission significantly improved congestion from the first day after administration by either dosing regimen, i.e. once-daily 7.5 mg or twice-daily 3.75 mg in patients with acute HF.

本文言語English
ページ(範囲)234-239
ページ数6
ジャーナルJournal of cardiology
72
3
DOI
出版ステータスPublished - 09-2018

All Science Journal Classification (ASJC) codes

  • 循環器および心血管医学

フィンガープリント

「Comparison of two dosing methods for immediate administration of tolvaptan in acute decompensated heart failure」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル